Dr. Dina Shrestha is a highly esteemed Consultant Endocrinologist with a remarkable track record in the field of endocrinology. With a wealth of experience and expertise, she has made significant contributions to the advancement of endocrine care in South Asia. Dr. Shrestha has held prestigious leadership roles, serving as the Immediate Past President of the South Asian Federation of Endocrine Societies (SAFES) and the Diabetes and Endocrine Association of Nepal (DEAN). Her commitment to improving healthcare is evident in her role as the Founder of the Diabetes Rehabilitation and Research Centre (DRRC), where she has spearheaded efforts to enhance diabetes care and research in Nepal.

As an accomplished academic, Dr. Dina Shrestha has left an indelible mark on the field of endocrinology. Her involvement as a member of the Editorial Board for The Journal of Clinical Endocrinology & Metabolism (JCEM) demonstrates her dedication to advancing scientific knowledge in the field. Moreover, Dr. Shrestha is an active participant in international advocacy efforts, serving as a member of the ISE Advocacy working group. Her research interests primarily focus on thyroid and diabetes in pregnancy, with a multitude of national and international publications that underscore her commitment to improving the lives of patients and contributing to the broader scientific community.

Currently, Dr. Shrestha continues to make a positive impact on patient care and medical research through her affiliations with Norvic International Hospital and Siddhi Polyclinic in Kathmandu. Her tireless dedication, leadership, and passion for endocrinology make her an invaluable asset to the medical community and a beacon of hope for individuals facing thyroid and diabetes-related challenges.

• Immediate Past President SAFES South Asian Federation of Endocrine Societies
• Immediate Past President DEAN Diabetes and Endocrine Association of Nepal
• Founder of DRRC Diabetes Rehabilitation and Research Centre
• JCEM Editorial Board The Journal of Clinical Endocrinology & Metabolism Member of the ISE Advocacy working group
• Chief Editor for the National Consensus statement of Type2DM and Hypothyroidism